Sort
48,018 grants matching “immunotherapy”
Enhancement of Biomarkers for Type 1 Diabetes
$736,066Massimo T Pietropaolo · University Of Michigan At Ann Arbor · R01 · FY2010 · DK
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$736,006Robert H Gilman · Johns Hopkins University · R01 · FY2019 · AI
T cells in the aging brain
$735,570Anne Brunet · Stanford University · R01 · FY2022 · AG
Administrative Core
$735,549Jun Yan · University Of Louisville · P20 · FY2022 · GM
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$735,428Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Protective Human Monoclonal Antibodies to HIV-1
$735,382Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2008 · HL
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
$735,360Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2024 · CA
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$735,324David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$735,324David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Redox Mechanism Process of Angiogenesis and Wound Healing
$735,236David Wink · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mechanisms and manipulation of force dependent behavior in T cell biology
$735,147Brian M Baker · University Of Notre Dame · R01 · FY2025 · AI
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
$735,043Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer
$734,981Kwok Kin Wong · New York University School Of Medicine · R01 · FY2024 · CA
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging
$734,970Matthew Spitzer · University Of California, San Francisco · R01 · FY2023 · DE
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$734,862Katerina Abigail Politi · Yale University · R01 · FY2019 · CA
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
$734,838Lyle L Moldawer · University Of Florida · R01 · FY2023 · GM
Human iPSC-Derived Chimeric Antigen Receptor Macrophages to Modulate Inflammation and Combat Tau-Induced Pathology
$734,778Jonathan N Sachs · University Of Minnesota · R61 · FY2025 · AG
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$734,575Shabaana A. Khader · Washington University · R01 · FY2017 · AI
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
$734,550Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2023 · CA
Molecular Diagnostics Core Laboratory
$734,451Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Project 1 - Clinical Trial
$734,412Andrew R Haas · University Of Pennsylvania · P01 · FY2022 · CA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$734,389Ticiana Leal · Emory University · UG1 · FY2022 · CA
Development of Drugs Acting at Adenosine Receptors
$734,314Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Redox Mechanism Process of Angiogenesis and Wound Healing
$734,276David Wink · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$734,238Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA